Blepharospasm drugs in development, 2023

GlobalData tracks 5 drugs in development for Blepharospasm by four companies/universities/institutes. The top development phase for Blepharospasm is phase ii, with two drugs in that stage.

California Attorney General boosts bill banning medical debt from credit reports

California Attorney General Rob Bonta announced Monday that he is throwing his weight behind legislation to bar medical debt from showing up on consumer credit

March 11, 2024

Behavioral Intervention Eases Chronic Pain for Dialysis Patients

A cognitive behavioral intervention eased chronic pain for people with kidney failure on maintenance hemodialysis, a randomized clinical trial found. After 12 weeks, pain coping

December 31, 2024

NICE recommends Ebglyss for atopic dermatitis patients – Pharmaceutical Technology

Around 5.2 million adults in the UK have moderate to severe atopic dermatitis. Image credit: Shutterstock / Kmpzzz. England’s National Institute for Health and Care

July 10, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.